| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/15/2003 | EP1274430A2 Compounds for treating fibromyalgia and chronic fatigue syndrome |
| 01/15/2003 | EP1155017B1 [1,8] naphthyridine derivatives having antiviral activity |
| 01/15/2003 | EP0912572B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/15/2003 | EP0862571B1 Herbicidal sulfonamides |
| 01/15/2003 | EP0851756B1 Use of ondansetron in the manufacture of a medicament for the treatment of tremor |
| 01/15/2003 | CN1391576A Androgen receptor modulator compounds and methods |
| 01/15/2003 | CN1391575A Nitrogen containing heterobicycles as factor XA inhibitors |
| 01/15/2003 | CN1391573A Bicyclic imidazo-3-yl-amine derivatives |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391558A Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 01/15/2003 | CN1391555A Benzamides and related inhibitors of factor Xa |
| 01/15/2003 | CN1098851C New ellipticine achroalkali compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | CN1098841C Novel amide derivatives and medicinal compositions thereof |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506773 Hydroxamic and carboxylic acid derivatives |
| 01/14/2003 | US6506772 Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. |
| 01/14/2003 | US6506771 Anticoagulants |
| 01/14/2003 | US6506770 Antiviral compounds |
| 01/14/2003 | US6506769 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/14/2003 | US6506768 Tetrahydro γ-carbolines |
| 01/14/2003 | US6506762 Certain alkylene diamine-substituted heterocycles |
| 01/14/2003 | US6506749 7-oxo-pyridopyrimidines (I) |
| 01/14/2003 | US6506567 Water-soluble flourescent intercalator compound |
| 01/09/2003 | WO2003002974A2 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 01/09/2003 | WO2003002562A1 Technical synthesis method for producing tropenol |
| 01/09/2003 | WO2003002561A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | WO2003002560A1 New derivatives of oxazolidinones as antibacterial agents |
| 01/09/2003 | WO2003002559A2 Piperidine compounds for use as orexin receptor antagonist |
| 01/09/2003 | WO2003002064A2 Fused pyrimidine dhfr inhibitors as antibacterials |
| 01/09/2003 | WO2003001887A2 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 01/09/2003 | WO2002064594A3 6-substituted pyrido-pyrimidines |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | US20030008898 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation |
| 01/09/2003 | US20030008894 Antimicrobial quinolones, their compositions and uses |
| 01/09/2003 | US20030008891 Substituted 3',4' -Di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof |
| 01/09/2003 | US20030008873 For therapy of cancer |
| 01/09/2003 | US20030008866 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 01/09/2003 | US20030008856 Treatment of septic shock |
| 01/09/2003 | US20030007934 Delivery of stimulants through an inhalation route |
| 01/09/2003 | US20030007933 Delivery of muscle relaxants through an inhalation route |
| 01/09/2003 | US20030005924 Delivery of beta-blockers through an inhalation route |
| 01/09/2003 | CA2451840A1 Fused pyrimidine dhfr inhibitors as antibacterials |
| 01/09/2003 | CA2451800A1 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 01/09/2003 | CA2451464A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | CA2450982A1 New derivatives of oxazolidinones as antibacterial agents |
| 01/08/2003 | EP1273575A1 Diazepane derivatives or salts thereof |
| 01/08/2003 | EP1272492A2 Method for producing triethylene diamine, using ethylene diamine |
| 01/08/2003 | EP1272491A1 Perylene-derivative based crystallization modifiers |
| 01/08/2003 | EP1272490A2 Sodium salt of an azo derivative of 5-aminosalicylic acid |
| 01/08/2003 | EP1272489A1 Process for preparing crystalline form i of cabergoline |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272479A2 Novel compounds for enhancing chemotherapy |
| 01/08/2003 | EP1272467A1 Cathepsin cysteine protease inhibitors |
| 01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
| 01/08/2003 | EP0946175B1 USE OF A COMBINATION OF H+, K+ -ATPase INHIBITORS AND GLUCOCORTICOIDS IN THE TREATMENT OF NASAL POLYPS |
| 01/08/2003 | EP0912564B1 Process for preparing tetrahydroimidazoquinolinamines |
| 01/08/2003 | EP0859768B1 Amine acid salt compounds and process for the production thereof |
| 01/08/2003 | EP0689437B1 Use of granisetron for the treatment of post-operative nausea and vomiting |
| 01/08/2003 | CN1390220A Kinase inhibitors as therapeutic agents |
| 01/08/2003 | CN1390218A New active marine alkaloids |
| 01/08/2003 | CN1390217A Bicyclic and tricyclic heteroaromatic compounds |
| 01/08/2003 | CN1390206A Inhibitors of factor Xa |
| 01/08/2003 | CN1390201A Cyclic amine compounds as CCR5-antagonists |
| 01/08/2003 | CN1389223A Composite Chinese medicine for treating malignant solid tumor and its prepn. |
| 01/07/2003 | US6503926 Nitrogen heterocycle compounds |
| 01/07/2003 | US6503923 Haloalkoxy imidazonaphthyridines |
| 01/07/2003 | US6503922 Central nervous system (CNS); bridged nicotine analogs of N-octylnicotinium iodide (NONI) having selective antagonist properties at alpha 3 beta 2-containing nicotinic receptor subtypes |
| 01/07/2003 | CA2252813C 3- and 3,8-substituted 1,10-phenanthrolines and their use in electron and energy transfer processes |
| 01/07/2003 | CA2075684C 1-acylpiperidine compounds |
| 01/03/2003 | WO2003000696A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 01/03/2003 | WO2003000692A2 Oxytocin agonists |
| 01/03/2003 | WO2003000691A1 Carboline derivatives as pdev inhibitors |
| 01/03/2003 | WO2003000690A1 Synthesis of heterocyclic compounds employing microwave technology |
| 01/03/2003 | WO2003000689A1 Imidazo`1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000682A1 (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| 01/03/2003 | WO2003000677A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/03/2003 | WO2003000665A1 Antibacterial uracil derivatives |
| 01/03/2003 | WO2003000270A1 Novel pyridopyrimidones and uses thereof |
| 01/03/2003 | WO2003000250A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/03/2003 | WO2003000011A2 Novel pyridopyrimidines and uses thereof |
| 01/03/2003 | WO2002085353A9 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor xa inhibitors |
| 01/03/2003 | WO2002080914A3 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments |
| 01/03/2003 | WO2001044260A8 Novel purines |
| 01/03/2003 | CA2451602A1 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease |
| 01/03/2003 | CA2451008A1 Imidazo¬1,2-a]pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 01/03/2003 | CA2450555A1 (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| 01/03/2003 | CA2450550A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/03/2003 | CA2450480A1 Oxytocin agonists |
| 01/03/2003 | CA2449441A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/02/2003 | US20030004358 Treatment of peptic ulcers |
| 01/02/2003 | US20030004351 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 01/02/2003 | US20030004350 Pyrrolo(2,3-b)pyridine derivatives; anticancer and antiproliferative agents |
| 01/02/2003 | US20030004344 Thrombin or factor Xa inhibitors |
| 01/02/2003 | US20030004181 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions |
| 01/02/2003 | US20030004180 Central nervous system disorders; psychological disorders |
| 01/02/2003 | US20030004171 Osteoporosis, restenosis, antiinflammatory agents |
| 01/02/2003 | US20030004167 Imidazo-heterobicycles as factor Xa inhibitors |
| 01/02/2003 | US20030004165 Polyazanaphthalene compounds and pharmaceutical use thereof |